[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100605481":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":39,"locations":45,"responsibleParty":59,"collaborators":26,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":67,"acronym":26,"eligibilityCriteria":68,"healthyVolunteers":64,"sex":69,"minAge":70,"maxAge":71,"enrollmentInfo":72,"targetDuration":26,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":81,"overallStatus":86,"whyStopped":26,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":96},{"fullName":5,"class":6},"Ohio State University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Conventional nutrient forms","ACTIVE_COMPARATOR","People are given a supplement with nutrient forms typically used in supplements",[13],"Dietary Supplement: Common form supplementation",{"label":15,"type":16,"description":17,"interventionNames":18},"Non-common nutrient forms","EXPERIMENTAL","People are given a supplement with nutrient forms that are not the most commonly used forms in supplements",[19],"Dietary Supplement: Uncommon nutrient supplementation",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DIETARY_SUPPLEMENT","Common form supplementation","The intervention product would represent part of a typical supplement given to people including those with CF",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Uncommon nutrient supplementation","The intervention product would represent part of a possible new supplement given to people including those with CF",[15],[32,35],{"name":33,"affiliation":5,"role":34},"Robert A Emeritus Professor","PRINCIPAL_INVESTIGATOR",{"name":36,"affiliation":37,"role":38},"Karen Faculty Pulmonary Medicine Nationwide Children's Hospital","Nationwide Children's Hospital","STUDY_DIRECTOR",[40],{"name":41,"role":42,"phone":43,"phoneExt":26,"email":44},"Stephanie Clinical Research Program Coordinato","CONTACT","614-722-2000","Stephanie.Sliemers@nationwidechildrens.org",[46],{"facility":47,"status":26,"city":48,"state":49,"zip":50,"country":51,"countryCode":52,"cosmosGeoPoint":53,"geoPoint":58,"contacts":26},"Nationwide Children's Hospital-Ohio State University","Columbus","Ohio","43016","United States","US",{"type":54,"coordinates":55},"Point",[56,57],-82.99879,39.96118,{"lat":57,"lon":56},{"type":34,"investigatorFullName":60,"investigatorTitle":61,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Robert DiSilvestro","Emeritus Pofessor","100605481","nutrition-supplement-for-cystic-fibrosis-100605481",false,"NCT07163078","Nutrition Supplement for Cystic Fibrosis","A Medical Nutrition Supplement for Cystic Fibrosis","Inclusion Criteria:\n\n* Diagnosed with cystic fibrosis\n* Diagnosed with exocrine pancreatic insufficiency\n* 18 years old or older\n* Currently on modulator\n* Normal liver enzyme labs\n\nExclusion Criteria: :\n\n* Non-English-speaking participants\n* Acute health crisis\n* Persistent elevation of liver enzymes \\>6 months (E2) (ALT \\>80 U\u002FL)\n* History of liver abnormalities\n* If patients are currently taking Category A or Category B in the LiverTox categorization system\n* Recent vitamin D supplementation of 30 mcg\u002Fday or higher, vitamin E supplements of 200 IU\u002Fday or higher, or copper at 2 mg\u002Fday or higher\n* Any other concern by investigator that the subject is inappropriate for inclusion\n* Patients who is on a reduced dose of a CFTR modulator\n* Patients on azole antifungals (voriconazole, itraconazole, posaconzole, \\>7 days of fluconazole, etc.).\n* Patients who binge drink EtOH - for men more than 2 drinks\u002Fday, for women more than 1 drink\u002F day\n* Patients that are on other medications that are sensitive CYP3A4 substrates - such as tacrolimus for example\n* Patients on sensitive CYP3A4 substrates including but not limited to tacrolimus, sirolimus, and cyclosporine","ALL","18 Years","50 Years",{"count":73,"type":74},60,"ESTIMATED","INTERVENTIONAL",[77],"NA","The goal of this study is to learn if one nutrition supplement formula works better than a different formula in adults with cystic fibrosis. The main question being addressed is: Will certain atypical versions of certain nutrients outperform typical versions of these nutrients? This will be determined by examining blood measures of nutrient levels and\u002For indications of nutrient function indicators pre- and post-intervention. Participants will take the supplements for 6 weeks with a blood draw before and after that time.",[80],"Cystic Fibrosis (CF)",[82,83,84,85],"Cystic Fibrosis","Vitamins","Copper","Choline","NOT_YET_RECRUITING","2026-06-05",{"date":89,"type":90},"2026-06-09","ACTUAL",{"date":92,"type":74},"2026-06",{"date":94,"type":74},"2027-01",{"name":5,"class":6},1]